Tandem Diabetes Care [TNDM] vs Artivion [AORT] Detailed Stock Comparison
Tandem Diabetes Care
NASDAQ
Loading...
Artivion
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Tandem Diabetes Care wins in 6 metrics, Artivion wins in 12 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Tandem Diabetes Care | Artivion | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -10.01 | -128.28 | Artivion |
| Price-to-Book Ratio | 7.45 | 4.61 | Artivion |
| Debt-to-Equity Ratio | 340.56 | 62.81 | Artivion |
| PEG Ratio | -0.15 | 0.80 | Tandem Diabetes Care |
| EV/EBITDA | -14.92 | 47.17 | Tandem Diabetes Care |
| Profit Margin (TTM) | -20.51% | -4.43% | Artivion |
| Operating Margin (TTM) | -13.24% | 9.72% | Artivion |
| EBITDA Margin (TTM) | N/A | 9.72% | N/A |
| Return on Equity | -111.92% | -5.02% | Artivion |
| Return on Assets (TTM) | -6.41% | 1.70% | Artivion |
| Free Cash Flow (TTM) | $4.99M | $11.05M | Artivion |
| 1-Year Return | -64.79% | 55.26% | Artivion |
| Price-to-Sales Ratio (TTM) | 0.99 | 4.78 | Tandem Diabetes Care |
| Enterprise Value | $1.13B | $2.15B | Artivion |
| EV/Revenue Ratio | 1.13 | 5.30 | Tandem Diabetes Care |
| Gross Profit Margin (TTM) | 52.29% | 64.72% | Artivion |
| Revenue per Share (TTM) | $15 | $10 | Tandem Diabetes Care |
| Earnings per Share (Diluted) | $-3.08 | $-0.43 | Artivion |
| Beta (Stock Volatility) | 1.49 | 1.67 | Tandem Diabetes Care |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Tandem Diabetes Care vs Artivion Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Tandem Diabetes Care | 12.20% | 22.58% | 19.11% | -12.34% | -16.70% | -58.96% |
| Artivion | 1.13% | -0.02% | -5.24% | 33.63% | 70.05% | 46.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Tandem Diabetes Care | -64.79% | -71.78% | -87.27% | -81.93% | -93.26% | -93.26% |
| Artivion | 55.26% | 254.18% | 112.58% | 301.27% | 563.17% | 478.98% |
News Based Sentiment: Tandem Diabetes Care vs Artivion
Tandem Diabetes Care
News based Sentiment: MIXED
October was a mixed month for Tandem, with a serious product malfunction investigation launching alongside a positive regulatory clearance. The investigation introduces significant risk, while the clearance offers a potential growth opportunity, creating a complex investment picture.
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
Performance & Financial Health Analysis: Tandem Diabetes Care vs Artivion
| Metric | TNDM | AORT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.01B | $1.98B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,690,569 | 388,190 |
| 90 Day Avg. Volume | 1,849,033 | 443,357 |
| Last Close | $14.71 | $41.05 |
| 52 Week Range | $9.98 - $42.70 | $21.97 - $45.07 |
| % from 52W High | -65.55% | -8.92% |
| All-Time High | $302.50 (Jan 13, 2014) | $45.07 (Aug 22, 2025) |
| % from All-Time High | -95.14% | -8.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.15% |
| Quarterly Earnings Growth | N/A | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | -0.04% |
| Operating Margin (TTM) | -0.13% | 0.10% |
| Return on Equity (TTM) | -1.12% | -0.05% |
| Debt to Equity (MRQ) | 340.56 | 62.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.97 | $8.91 |
| Cash per Share (MRQ) | $4.67 | $1.13 |
| Operating Cash Flow (TTM) | $9.72M | $19.65M |
| Levered Free Cash Flow (TTM) | $31.96M | $-12,697,875 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Tandem Diabetes Care vs Artivion
| Metric | TNDM | AORT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -10.01 | -128.28 |
| Forward P/E | -12.16 | 171.04 |
| PEG Ratio | -0.15 | 0.80 |
| Price to Sales (TTM) | 0.99 | 4.78 |
| Price to Book (MRQ) | 7.45 | 4.61 |
| Market Capitalization | ||
| Market Capitalization | $1.01B | $1.98B |
| Enterprise Value | $1.13B | $2.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.13 | 5.30 |
| Enterprise to EBITDA | -14.92 | 47.17 |
| Risk & Other Metrics | ||
| Beta | 1.49 | 1.67 |
| Book Value per Share (MRQ) | $1.97 | $8.91 |
Financial Statements Comparison: Tandem Diabetes Care vs Artivion
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TNDM | AORT |
|---|---|---|
| Revenue/Sales | $234.42M | $112.97M |
| Cost of Goods Sold | $116.02M | $39.86M |
| Gross Profit | $118.41M | $73.11M |
| Research & Development | $125.43M | $7.06M |
| Operating Income (EBIT) | $-120.88M | $8.38M |
| EBITDA | $-116.42M | $18.95M |
| Pre-Tax Income | $-122.09M | $3.48M |
| Income Tax | $8.47M | $2.14M |
| Net Income (Profit) | $-130.56M | $1.35M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TNDM | AORT |
|---|---|---|
| Cash & Equivalents | $53.57M | $37.69M |
| Total Current Assets | $663.44M | $287.30M |
| Total Current Liabilities | $288.18M | $51.94M |
| Long-Term Debt | $431.75M | $356.98M |
| Total Shareholders Equity | $155.29M | $294.25M |
| Retained Earnings | $-1.18B | $-61.77M |
| Property, Plant & Equipment | $79.22M | $77.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TNDM | AORT |
|---|---|---|
| Operating Cash Flow | $-6.71M | $-17.94M |
| Capital Expenditures | $-6.21M | N/A |
| Free Cash Flow | $-15.70M | $-20.59M |
| Debt Repayment | $-40.76M | $-66,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TNDM | AORT |
|---|---|---|
| Shares Short | 7.93M | 1.08M |
| Short Ratio | 4.28 | 2.52 |
| Short % of Float | 0.16% | 0.03% |
| Average Daily Volume (10 Day) | 1,690,569 | 388,190 |
| Average Daily Volume (90 Day) | 1,849,033 | 443,357 |
| Shares Outstanding | 66.26M | 41.95M |
| Float Shares | 61.82M | 41.61M |
| % Held by Insiders | 0.01% | 0.05% |
| % Held by Institutions | 1.20% | 0.90% |
Dividend Analysis & Yield Comparison: Tandem Diabetes Care vs Artivion
| Metric | TNDM | AORT |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |